Sponsor Benefits

Global Health Network assists you by providing you with the following value-added benefits:

Quick Response...

Global can typically respond to protocols within 72 hours of your request. We have a strong working relationship with our large network of investigators (over 750), which allows us to quickly identify, evaluate and screen sites for clinical trials. We also work closely with central and local IRBs to ensure a smooth, efficient approval process.

Quality Patient Enrollment...

At Global, we make quality patient enrollment a number-one priority. The success or failure of a clinical trial rests on the ability to target and recruit qualified patients to participate through the entire trial period.

Through our extensive national investigator network, we have immediate access to a broad demographic base from which to identify and recruit the best patient candidates.

Throughout the entire process, we facilitate effective coordination of information between sponsor, investigator and patient.

Select Sites...

Global Select Sites are made up of a therapeutically diverse group of high performance, pre-qualified sites with a proven track record.* Our Select Sites have demonstrated the ability to start up projects quickly, meet enrollment goal timelines, and produce quality data. Our Select Sites have the expertise to substantially improve and accelerate the development of new drug biologies.

Global Select Sites can play a vital role in getting your product to market faster. Global Select Sites have been carefully chosen and monitored. At Global, we maintain extensive confidential investigator/site profiles which allows us to evaluate each site on a per-study basis. Our investigator network must maintain their credentials, research interest, experience, constantly increase their patient population, and maintain a quality working relationship with Global. Unlike other SMOs, Global is not a research broker.

*Go to the Sample Forms pages to see how we qualify sites and investigators.

Experienced Investigators...

Our investigator network is national in scope, composed of more than 750 board-certified physicians – all with clinical trial backgrounds. Global works with the finest physician investigators in the nation. All of our investigators are in private practice, affiliated with renowned medical teaching facilities or affiliated with public hospitals around the country. All have extensive experience working with clinical trials.

Because we work so closely with our investigators, Global can meet a wide variety of sponsor needs with speed and efficiency. We manage our investigators via our national database, so that we can access and match therapeutic specialties to sponsor/CRO needs quickly and accurately.

Site Support...

Global Site Support Resources (GSSR) is a unique new service provided by Global to all of our investigators. Through this service, Global delivers efficient on-site study coordinators, utilizing well-trained (using Good Clinical Practice (GCP) Standards), highly skilled Clinical Research Associates (CRAs)

Our CRAs are able to work on a local, regional, or national level for short-term or long-term assignments. We developed this program for investigators who are dedicated to research and who have the recruitment capabilities, but are either short-staffed or have a vacancy in their CRA department and need site support.

Global offers the most quality focused and cost efficient way to achieve effective study execution at the site level by supplying the site with professional, experienced CRAs who already possess the necessary technological and research knowledge.

Budgeting/Contracting...

We at Global recognize that valuable time can be wasted with the study review process. Our detailed screening review can quickly determine whether we have the investigator with the qualified patients and a budget within which he/she can work. Our philosophy dictates that we quickly tell you whether we can or cannot conduct your study. All contracts are between Global and the sponsor/CRO. We maintain our own set of such agreements with our own investigators and ancillary service providers.